Back to search

France· FR:60168515

NEORECORMON 30 000 UI, solution injectable en seringue préremplie

A medicinal product containing époétine bêta, registered in France by ROCHE REGISTRATION (ALLEMAGNE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNEORECORMON 30 000 UI, solution injec…ATC—REGISTER NO.FR:60168515PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ÉPOÉTINE BÊTA
Manufacturer
ROCHE REGISTRATION (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400936346567
    1 seringue(s) préremplie(s) en verre avec 1 aiguille(s)
  • cip13
    3400936346628
    4 seringue(s) préremplie(s) en verre avec 4 aiguille(s)
    EUR 494.39

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Époétine bêta in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All époétine bêta products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Erypo
  • Belgium · Eprex
  • Czechia · Eprex
  • Germany · Erypo Fs
  • Spain · Eprex
  • United Kingdom (Northern Ireland) · Eprex
  • Greece · Eprex
  • Iceland · Abseamed, Binocrit
  • Italy · Eprex
  • Liechtenstein · Binocrit, Epoetin Alfa Hexal
  • Luxembourg · Eprex
  • Netherlands · Eprex
  • Norway · Abseamed, Binocrit
  • Portugal · Eprex
  • Slovenia · Eprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d57333b2-a390-438d-a72d-72eb7482f8d8
GET /v1/drugs/d57333b2-a390-438d-a72d-72eb7482f8d8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60168515",
  "date_amm": "2004-02-23",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/97/031",
  "substance": "ÉPOÉTINE BÊTA",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse;sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about époétine bêta.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.